134 related articles for article (PubMed ID: 484251)
1. The effects of a beta 1-blocking agent, atenolol, on blood pressure, plasma renin activity and prostaglandin F2 alpha excretion in patients with essential hypertension.
Pitkäjärvi T; Ylitalo P; Metsä-Ketelä T; Vapaatalo H
Acta Med Scand; 1979; 206(1-2):107-13. PubMed ID: 484251
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of prostaglandin synthesis by indomethacin interacts with the antihypertensive effect of atenolol.
Ylitalo P; Pitkäjärvi T; Pyykönen ML; Nurmi AK; Seppälä E; Vapaatalo H
Clin Pharmacol Ther; 1985 Oct; 38(4):443-9. PubMed ID: 3899459
[TBL] [Abstract][Full Text] [Related]
3. Atenolol administered once daily in primary hypertension. Effects on blood pressure in relation to pre-treatment plasma renin activity.
Nilsson OR; Karlberg BE; Ohlsson O; Thulin T; Tolagen K
Acta Med Scand; 1979; 206(4):303-8. PubMed ID: 506802
[TBL] [Abstract][Full Text] [Related]
4. Effects of the direct renin inhibitor aliskiren and atenolol alone or in combination in patients with hypertension.
Dietz R; Dechend R; Yu CM; Bheda M; Ford J; Prescott MF; Keefe DL
J Renin Angiotensin Aldosterone Syst; 2008 Sep; 9(3):163-75. PubMed ID: 18957387
[TBL] [Abstract][Full Text] [Related]
5. The effect of inhibition of prostaglandin synthesis on plasma renin activity and blood pressure in essential hypertension.
Ylitalo P; Pitkäjärvi T; Metsä-Ketelä T; Vapaatalo H
Prostaglandins Med; 1978 Dec; 1(6):479-88. PubMed ID: 733979
[TBL] [Abstract][Full Text] [Related]
6. Atenolol and chlorthalidone on blood pressure, heart rate, and plasma renin activity in hypertension.
Teeuw AH; Leenen FH; Geyskes GG; Boer P
Clin Pharmacol Ther; 1979 Mar; 25(3):294-302. PubMed ID: 367678
[TBL] [Abstract][Full Text] [Related]
7. Effect of atenolol treatment on urinary prostaglandins E2 and F2 alpha in essential hypertension.
Rathaus M; Magen A; Rath-Wolfson L; Shapira J; Bernheim J
Isr J Med Sci; 1983 Dec; 19(12):1072-4. PubMed ID: 6582055
[TBL] [Abstract][Full Text] [Related]
8. A dose ranging study of atenolol in hypertension: fall in blood pressure and plasma renin activity, beta-blockade and steady-state pharmacokinetics.
Ishizaki T; Oyama Y; Suganuma T; Sasaki T; Nakaya H; Shibuya T; Sato T
Br J Clin Pharmacol; 1983 Jul; 16(1):17-25. PubMed ID: 6349668
[TBL] [Abstract][Full Text] [Related]
9. Effects of propranolol and atenolol on plasma renin activity and systolic time intervals in borderline hypertension.
González-Gómez A; García-Barreto D; Gamio Capestany F; Hernández-Cañero A; Fong Chi S
Cor Vasa; 1982; 24(6):422-8. PubMed ID: 6764167
[TBL] [Abstract][Full Text] [Related]
10. Metoprolol and atenolol administered once daily in primary hypertension. A clinical comparison of the efficacy of two selective beta-adrenoceptor blocking agents.
Lyngstam O; Rydén L
Acta Med Scand; 1981; 209(4):261-6. PubMed ID: 7015797
[TBL] [Abstract][Full Text] [Related]
11. Effect of atenolol, a new cardioselective beta-blocker, on plasma renin activity in treatment of hypertension.
Balansard P; Chabrillat Y; Paulin R; Libes M; Gérard R
Acta Cardiol; 1977; 32(4):229-43. PubMed ID: 304291
[TBL] [Abstract][Full Text] [Related]
12. Antihypertensive and metabolic effects of increasing doses of atenolol and labetalol. A comparative study in primary hypertension.
Nilsson OR; Karlberg BE; Henningsen NC; Thulin T
Acta Med Scand Suppl; 1982; 665():117-9. PubMed ID: 6760679
[TBL] [Abstract][Full Text] [Related]
13. Short-term effects of atenolol and nifedipine on atrial natriuretic peptide, plasma renin activity, and plasma aldosterone in patients with essential hypertension.
Colantonio D; Casale R; Desiati P; Giandomenico G; Bucci V; Pasqualetti P
J Clin Pharmacol; 1991 Mar; 31(3):238-42. PubMed ID: 1826912
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy and tolerability of a cardioselective beta-blocking drug (atenolol) in the treatment of essential hypertension. A double blind study (author's transl)].
Rengo F; Trimarco B; Petretta M; Ferrara N; Bonaduce D; Chiariello M; Condorelli M
G Ital Cardiol; 1978; 8(8):861-7. PubMed ID: 359398
[TBL] [Abstract][Full Text] [Related]
15. Time-course of the anti-hypertensive action of atenolol: comparison of response to first dose and to maintained oral administration.
Leonetti G; Terzoli L; Bianchini C; Sala C; Zanchetti A
Eur J Clin Pharmacol; 1980 Nov; 18(5):365-74. PubMed ID: 7002567
[TBL] [Abstract][Full Text] [Related]
16. Effects of atenolol and enalapril on blood pressure, plasma renin activity and urinary prostanoids.
Wilson TW
Clin Invest Med; 1988 Jun; 11(3):203-8. PubMed ID: 2841053
[TBL] [Abstract][Full Text] [Related]
17. Effects of prostaglandins inhibition on changes in active and inactive renin induced by antihypertensive drugs.
Salvetti A; Pedrinelli R; Sassano P; Arzilli F; Turini F
Clin Exp Hypertens A; 1982; 4(11-12):2435-48. PubMed ID: 6756707
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin excretion after furosemide in normal and low-renin essential hypertension.
Scherer B; Witzgall H; Weber PC
Klin Wochenschr; 1984 Aug; 62(16):777-82. PubMed ID: 6384651
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Blood Pressure Control Rates Among Recommended Drug Selection Strategies for Initial Therapy of Hypertension.
Gharaibeh KA; Turner ST; Hamadah AM; Chapman AB; Cooper-Dehoff RM; Johnson JA; Gums JG; Bailey KR; Schwartz GL
Am J Hypertens; 2016 Oct; 29(10):1186-94. PubMed ID: 27365079
[TBL] [Abstract][Full Text] [Related]
20. Effects of propranolol and atenolol on blood pressure and plasma renin activity in patients with moderate hypertension.
Epstein SE; LUbbe WF
S Afr Med J; 1977 Nov; 52(22):875-9. PubMed ID: 343273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
